Gut molecule research could help control glucose levels 29 January 2018 Most of us know that insulin plays an important role in removing excess glucose from the blood, but did you know it isn’t the only molecule involved in the process? Another molecule that plays a role is glucagon-like peptide-1 (GLP-1). Now Professor Marco Falasca and his team from Curtin University, with the support of Diabetes Australia, are investigating ways of increasing the amount of GLP-1 somebody produces and whether that can help control glucose levels. “We know GLP-1 is released in the gut when people eat. It has a key role to play in regulating blood glucose levels,” Professor Falasca said. “We also know that people with diabetes have a decreased ability to release GLP-1, so what we want to do it find a way of increasing the body’s production of the molecule. “Researchers have tried to produce drugs that mimic GLP-1 but they haven’t been too successful so we are trying a different approach. “There is a compound in the body, belonging to the lipid family, which stimulates the release and production of GLP-1. What we are trying to do is determine if this lipid, or molecules similar to it, can be used to stimulate the production of GLP-1. “Hopefully, if we are successful, this could lead to a new therapy for supporting people with diabetes.” If you are interested in helping Diabetes Australia support research like this you can find out more here.
News 3 July 2026 Daonil to be discontinued in Australia People living with type 2 diabetes who use Daonil are encouraged to speak with their doctor or diabetes healthcare team... Continue Reading
News 30 June 2026 PBS listing of Tresiba Penfill good news for people living with type 1 diabetes Diabetes Australia has welcomed the Australian Government’s decision to list Tresiba Penfill (insulin degludec) on the Pharmaceutical Benefits Scheme (PBS) for people... Continue Reading
Media releases 18 June 2026 Hope for Australians living with cystic fibrosis and diabetes as new research targets breakthrough treatment A leading diabetes and respiratory researcher is investigating whether a breakthrough cystic fibrosis treatment could change the course of a serious form of diabetes affecting Australians living with cystic fibrosis. Continue Reading